CN104017042A - Separation purification method for 7-dehydrocholesterol - Google Patents

Separation purification method for 7-dehydrocholesterol Download PDF

Info

Publication number
CN104017042A
CN104017042A CN201410210759.2A CN201410210759A CN104017042A CN 104017042 A CN104017042 A CN 104017042A CN 201410210759 A CN201410210759 A CN 201410210759A CN 104017042 A CN104017042 A CN 104017042A
Authority
CN
China
Prior art keywords
dhc
normal hexane
suction filtration
purification method
crystallization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410210759.2A
Other languages
Chinese (zh)
Other versions
CN104017042B (en
Inventor
马志军
薛家禄
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Big Biological Medicine Co Of Henan Profit Limited-Liability Co
Original Assignee
Big Biological Medicine Co Of Henan Profit Limited-Liability Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Big Biological Medicine Co Of Henan Profit Limited-Liability Co filed Critical Big Biological Medicine Co Of Henan Profit Limited-Liability Co
Priority to CN201410210759.2A priority Critical patent/CN104017042B/en
Publication of CN104017042A publication Critical patent/CN104017042A/en
Application granted granted Critical
Publication of CN104017042B publication Critical patent/CN104017042B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Steroid Compounds (AREA)

Abstract

The invention discloses a separation purification method for 7-dehydrocholesterol. The method comprises: firstly dissolving a 7-dehydrocholesterol fermentation material obtained in a biosynthetic process of cholesterol in solvents of hexane and water, fully stirring, filtering, standing for layering, so as to obtain a water phase and an organic phase; distilling the organic phase to remove hexane, then adding methanol, heating with stirring, after stirring is finished, performing pumping filtration, so as to obtain a filtrate and a filter residue; reducing the temperature of the filtrate for crystallization, and performing pumping filtration, so as to obtain cholesterol; adding a mixture of hexane and methanol in to the filter residue, heating with stirring, after full stirring is finished, performing pressure-reduction distillation, after distillation is performed, performing temperature-reduction crystallization and pumping filtration on the residue, so as to obtain a high-purity product 7-dehydrocholesterol. The method is capable of effectively separating and purifying high-purity 7-dehydrocholesterol from a product 7-dehydrocholesterol fermentation material, and also effectively recovering unconverted cholesterol and utilizing cholesterol for once-more feeding, so that the raw material is utilized to a relatively high degree, and accords with demands of current sustainable economic development.

Description

A kind of separation purification method of 7-DHC
Technical field
The present invention relates to a kind of organic method of purification, particularly relate to a kind of separation purification method of 7-DHC.
Background technology
7-DHC (7-DHC) is a kind of steroid material.Be present in the sebiferous gland and secretory product thereof in animal skin.7-DHC is white crystalline powder or light yellow crystalline powder, and its molecular formula is C 27h 44o, also claims vitamins D 3former.In human body, can be transformed by cholesterol.It is stored in subcutaneous, under daylight or uviolizing, can change vitamins D into 3, there is the biological activity that regulates calcium, phosphorus metabolism.Therefore, children's get sun more or carry out according to plan uviolizing can preventing child rickets.
7-DHC main application is: it is synthesis of vitamin d 3important intermediate, also as the additive in skin care sun care preparations.
At present, the preparation method of 7-DHC is generally: the one, and 7-DHC is separation and Extraction in pigskin; The 2nd, utilize cholesterol to obtain through acidylate, oxidation, hydrazone, de-hydrazone, saponification, a kind of medicine intermediate that 7-DHC saponification reaction is synthetic.Utilizing the synthetic 7-DHC of cholesterol bio-transformation is the synthetic method of having succeeded in developing at present, but does not carry out large-scale industrial production.
But, utilize cholesterol to carry out in bio-transformation synthetic method, the product obtaining is 7-DHC fermented material, contains microzyme culture medium, unconverted raw material cholesterol and 7-DHC in the 7-DHC fermented material obtaining.Therefore, want to obtain the 7-DHC product that purity is higher, need to study a kind of from product 7-DHC fermented material the effective method of separating-purifying 7-DHC.
Summary of the invention
The technical problem to be solved in the present invention is: provide a kind of from product 7-DHC fermented material the effective method of separating-purifying 7-DHC, the invention provides a kind of separation purification method of 7-DHC.Utilize technical solution of the present invention can be effectively from product 7-DHC fermented material separating-purifying go out 7-DHC, and can the unconverted cholesterol of efficient recovery, it is reused for again and feeds intake.Utilize technical solution of the present invention can access the 7-DHC product that purity is greater than 98%.
In order to address the above problem, the technical scheme that the present invention takes is:
The invention provides a kind of separation purification method of 7-DHC, described separation purification method comprises the following steps:
A, utilize existing cholesterol bio-transformation synthetic method to obtain 7-DHC fermented material in contain microzyme culture medium, unconverted raw material cholesterol and 7-DHC; First gained 7-DHC fermented material is dissolved in solvent normal hexane, and adds water, the add-on of described normal hexane and water is 5~10 times of 7-DHC fermented material volume, stirs at normal temperatures 1~1.5h after adding normal hexane and water; After stirring, filter, remove water insoluble and impurity normal hexane; Gained filtrate stratification, then carries out separatory, separates water and organic phase; After separatory, adopt normal hexane washing gained water 2~3 times, merge organic phase;
B, the organic phase that step a is obtained are distilled, and except desolventizing normal hexane, add the methyl alcohol of 48~52 times of volumes in the product obtaining, and are heated to 64~66 ℃, stir with this understanding 1.5~2 hours, carry out suction filtration after stirring, obtain filtrate and filter residue after suction filtration;
C, the filtrate that step b is obtained are cooled to room temperature and carry out crystallization, carry out suction filtration after crystallization, obtain cholesterol;
D, the filter residue that step b is obtained add in the mixture of normal hexane and methyl alcohol, and the volume ratio of the mixture of described filter residue and normal hexane and methyl alcohol between the two is 1:10~12, volume ratio 1:1 when described normal hexane and methanol mixed between the two; Then be warming up to 40 ℃~45 ℃, under this temperature condition, stir 1~1.5 hour; After stirring, gained liquid distills under vacuum tightness 0.09MPa, 10~15 ℃ of conditions, is distilled to 30~35% of primary liquid volume; Then decrease temperature crystalline, carries out suction filtration after crystallization, finally obtains high purity product 7-DHC.
According to the separation purification method of above-mentioned 7-DHC, after stirring described in step b, carry out suction filtration, during its suction filtration, vacuum tightness is that 0.09MPa, temperature are 15~20 ℃.
According to the separation purification method of above-mentioned 7-DHC, crystallization time during crystallization described in step c is 12~14h.
According to the separation purification method of above-mentioned 7-DHC, vacuum tightness is that 0.09MPa, temperature are normal temperature during suction filtration described in step c.
According to the separation purification method of above-mentioned 7-DHC, the volume ratio of the mixture of filter residue described in steps d and normal hexane and methyl alcohol between the two is 1:10.
According to the separation purification method of above-mentioned 7-DHC, decrease temperature crystalline described in steps d carries out crystallization 5~6 hours for being cooled to 0 ℃; After described crystallization, carry out suction filtration, during suction filtration, vacuum tightness is that 0.09 MPa, temperature are 0 ℃.
According to the separation purification method of above-mentioned 7-DHC, the purity of the 7-DHC of high purity product described in steps d is greater than 98%.
positive beneficial effect of the present invention:
1, utilize technical solution of the present invention can be effectively from product 7-DHC fermented material separating-purifying go out 7-DHC, and can the unconverted cholesterol of efficient recovery, it is reused for again feeds intake, thereby its raw material is utilized greatly, meet the demand of current sustainable economic development.
2, utilize technical solution of the present invention can access the 7-DHC product that purity is greater than 98%, meet better the market requirement higher to its product purity.
3, adopt at present chemical method to produce in 7-DHC technological process and will use 8 kinds of poisonous and hazardous organic solvents, and the raw material of separating-purifying of the present invention is to adopt biotransformation method synthetic, and only in the product separation stage, use a small amount of (being generally two kinds) organic solvent in biotransformation method building-up process.Reduce pollutant emission, protected physical environment, met biological fermentation production trend in the world.
4, the present invention has all made atlas analysis to the 7-DHC standard substance of selling on market and products obtained therefrom of the present invention, and by analysis: standard substance purity is 92%, product purity of the present invention is that 98.24%(refers to accompanying drawing 1,2).
accompanying drawing explanation:
The liquid-phase chromatographic analysis figure of Fig. 1 7-DHC standard substance;
The liquid-phase chromatographic analysis figure of Fig. 2 product 7-DHC of the present invention.
embodiment:
Below in conjunction with embodiment, further set forth the present invention, but do not limit content of the present invention.
Embodiment 1:
The separation purification method of 7-DHC of the present invention, the detailed step of this separation purification method is as follows:
A, utilize existing cholesterol bio-transformation synthetic method to obtain 7-DHC fermented material in contain microzyme culture medium, unconverted raw material cholesterol and 7-DHC; First gained 7-DHC fermented material is dissolved in solvent normal hexane, and adds water, the add-on of described normal hexane and water is 8 times of 7-DHC fermented material volume, stirs at normal temperatures 1.2h after adding normal hexane and water; After stirring, filter, remove water insoluble and impurity normal hexane; Gained filtrate stratification, then carries out separatory, separates water and organic phase; After separatory, adopt normal hexane washing gained water 3 times, merge organic phase;
B, the organic phase that step a is obtained are distilled, except desolventizing normal hexane, in the product obtaining, add the methyl alcohol of 50 times of volumes, be heated to 65 ℃, stir with this understanding 1.8 hours, after stirring, carry out suction filtration, during suction filtration, vacuum tightness is that 0.09MPa, temperature are 20 ℃, obtains filtrate and filter residue after suction filtration;
C, the filtrate that step b is obtained are cooled to room temperature and carry out crystallization 12h, carry out suction filtration after crystallization, and during suction filtration, vacuum tightness is that 0.09MPa, temperature are normal temperature, obtains cholesterol;
D, the filter residue that step b is obtained add in the mixture of normal hexane and methyl alcohol, and the volume ratio of the mixture of described filter residue and normal hexane and methyl alcohol between the two is 1:10, volume ratio 1:1 when described normal hexane and methanol mixed between the two; Then be warming up to 45 ℃, under this temperature condition, stir 1 hour; After stirring, gained liquid distills under vacuum tightness 0.09MPa, 15 ℃ of conditions, is distilled to 33% of primary liquid volume; Then be cooled to 0 ℃ and carry out crystallization 5 hours, carry out suction filtration after crystallization, during suction filtration, vacuum tightness is that 0.09 MPa, temperature are 0 ℃, finally obtains high purity product 7-DHC (products obtained therefrom purity is 98.24%, refers to accompanying drawing 2).
Embodiment 2:
The separation purification method of 7-DHC of the present invention, the detailed step of this separation purification method is as follows:
A, utilize existing cholesterol bio-transformation synthetic method to obtain 7-DHC fermented material in contain microzyme culture medium, unconverted raw material cholesterol and 7-DHC; First gained 7-DHC fermented material is dissolved in solvent normal hexane, and adds water, the add-on of described normal hexane and water is 10 times of 7-DHC fermented material volume, stirs at normal temperatures 1h after adding normal hexane and water; After stirring, filter, remove water insoluble and impurity normal hexane; Gained filtrate stratification, then carries out separatory, separates water and organic phase; After separatory, adopt normal hexane washing gained water 2 times, merge organic phase;
B, the organic phase that step a is obtained are distilled, except desolventizing normal hexane, in the product obtaining, add the methyl alcohol of 48 times of volumes, be heated to 64 ℃, stir with this understanding 2.0 hours, after stirring, carry out suction filtration, during suction filtration, vacuum tightness is that 0.09MPa, temperature are 18 ℃, obtains filtrate and filter residue after suction filtration;
C, the filtrate that step b is obtained are cooled to room temperature and carry out crystallization 13h, carry out suction filtration after crystallization, and during suction filtration, vacuum tightness is that 0.09MPa, temperature are normal temperature, obtains cholesterol;
D, the filter residue that step b is obtained add in the mixture of normal hexane and methyl alcohol, and the volume ratio of the mixture of described filter residue and normal hexane and methyl alcohol between the two is 1:11, volume ratio 1:1 when described normal hexane and methanol mixed between the two; Then be warming up to 40 ℃, under this temperature condition, stir 1.5 hours; After stirring, gained liquid distills under vacuum tightness 0.09MPa, 10 ℃ of conditions, is distilled to 30% of primary liquid volume; Then be cooled to 0 ℃ and carry out crystallization 6 hours, carry out suction filtration after crystallization, during suction filtration, vacuum tightness is that 0.09 MPa, temperature are 0 ℃, finally obtains high purity product 7-DHC.
Embodiment 3:
The separation purification method of 7-DHC of the present invention, the detailed step of this separation purification method is as follows:
A, utilize existing cholesterol bio-transformation synthetic method to obtain 7-DHC fermented material in contain microzyme culture medium, unconverted raw material cholesterol and 7-DHC; First gained 7-DHC fermented material is dissolved in solvent normal hexane, and adds water, the add-on of described normal hexane and water is 5 times of 7-DHC fermented material volume, stirs at normal temperatures 1.5h after adding normal hexane and water; After stirring, filter, remove water insoluble and impurity normal hexane; Gained filtrate stratification, then carries out separatory, separates water and organic phase; After separatory, adopt normal hexane washing gained water 3 times, merge organic phase;
B, the organic phase that step a is obtained are distilled, except desolventizing normal hexane, in the product obtaining, add the methyl alcohol of 50 times of volumes, be heated to 66 ℃, stir with this understanding 1.5 hours, after stirring, carry out suction filtration, during suction filtration, vacuum tightness is that 0.09MPa, temperature are 15 ℃, obtains filtrate and filter residue after suction filtration;
C, the filtrate that step b is obtained are cooled to room temperature and carry out crystallization 14h, carry out suction filtration after crystallization, and during suction filtration, vacuum tightness is that 0.09MPa, temperature are normal temperature, obtains cholesterol;
D, the filter residue that step b is obtained add in the mixture of normal hexane and methyl alcohol, and the volume ratio of the mixture of described filter residue and normal hexane and methyl alcohol between the two is 1:12, volume ratio 1:1 when described normal hexane and methanol mixed between the two; Then be warming up to 43 ℃, under this temperature condition, stir 1.2 hours; After stirring, gained liquid distills under vacuum tightness 0.09MPa, 15 ℃ of conditions, is distilled to 35% of primary liquid volume; Then be cooled to 0 ℃ and carry out crystallization 5 hours, carry out suction filtration after crystallization, during suction filtration, vacuum tightness is that 0.09 MPa, temperature are 0 ℃, finally obtains high purity product 7-DHC.

Claims (7)

1. a separation purification method for 7-DHC, is characterized in that, described separation purification method comprises the following steps:
A, utilize existing cholesterol bio-transformation synthetic method to obtain 7-DHC fermented material in contain microzyme culture medium, unconverted raw material cholesterol and 7-DHC; First gained 7-DHC fermented material is dissolved in solvent normal hexane, and adds water, the add-on of described normal hexane and water is 5~10 times of 7-DHC fermented material volume, stirs at normal temperatures 1~1.5h after adding normal hexane and water; After stirring, filter, remove water insoluble and impurity normal hexane; Gained filtrate stratification, then carries out separatory, separates water and organic phase; After separatory, adopt normal hexane washing gained water 2~3 times, merge organic phase;
B, the organic phase that step a is obtained are distilled, and except desolventizing normal hexane, add the methyl alcohol of 48~52 times of volumes in the product obtaining, and are heated to 64~66 ℃, stir with this understanding 1.5~2 hours, carry out suction filtration after stirring, obtain filtrate and filter residue after suction filtration;
C, the filtrate that step b is obtained are cooled to room temperature and carry out crystallization, carry out suction filtration after crystallization, obtain cholesterol;
D, the filter residue that step b is obtained add in the mixture of normal hexane and methyl alcohol, and the volume ratio of the mixture of described filter residue and normal hexane and methyl alcohol between the two is 1:10~12, volume ratio 1:1 when described normal hexane and methanol mixed between the two; Then be warming up to 40 ℃~45 ℃, under this temperature condition, stir 1~1.5 hour; After stirring, gained liquid distills under vacuum tightness 0.09MPa, 10~15 ℃ of conditions, is distilled to 30~35% of primary liquid volume; Then decrease temperature crystalline, carries out suction filtration after crystallization, finally obtains high purity product 7-DHC.
2. the separation purification method of 7-DHC according to claim 1, is characterized in that: after stirring described in step b, carry out suction filtration, during its suction filtration, vacuum tightness is that 0.09MPa, temperature are 15~20 ℃.
3. the separation purification method of 7-DHC according to claim 1, is characterized in that: crystallization time during crystallization described in step c is 12~14h.
4. the separation purification method of 7-DHC according to claim 1, is characterized in that: described in step c, vacuum tightness is that 0.09MPa, temperature are normal temperature during suction filtration.
5. the separation purification method of 7-DHC according to claim 1, is characterized in that: the volume ratio of the mixture of filter residue described in steps d and normal hexane and methyl alcohol between the two is 1:10.
6. the separation purification method of 7-DHC according to claim 1, is characterized in that: decrease temperature crystalline described in steps d carries out crystallization 5~6 hours for being cooled to 0 ℃; After described crystallization, carry out suction filtration, during suction filtration, vacuum tightness is that 0.09 MPa, temperature are 0 ℃.
7. the separation purification method of 7-DHC according to claim 1, is characterized in that: the purity of the 7-DHC of high purity product described in steps d is greater than 98%.
CN201410210759.2A 2014-05-19 2014-05-19 A kind of separation purification method of 7-DHC Active CN104017042B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410210759.2A CN104017042B (en) 2014-05-19 2014-05-19 A kind of separation purification method of 7-DHC

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410210759.2A CN104017042B (en) 2014-05-19 2014-05-19 A kind of separation purification method of 7-DHC

Publications (2)

Publication Number Publication Date
CN104017042A true CN104017042A (en) 2014-09-03
CN104017042B CN104017042B (en) 2016-01-06

Family

ID=51434085

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410210759.2A Active CN104017042B (en) 2014-05-19 2014-05-19 A kind of separation purification method of 7-DHC

Country Status (1)

Country Link
CN (1) CN104017042B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020104353A1 (en) * 2018-11-19 2020-05-28 Dsm Ip Assets B.V. 7-dehydrocholesterol-hemimethanolate
CN112979738A (en) * 2021-03-02 2021-06-18 浙江新和成股份有限公司 Crystallization purification method of 7-dehydrocholesterol and application thereof in VD3 production
CN115397832A (en) * 2020-04-23 2022-11-25 帝斯曼知识产权资产管理有限公司 Nanofiltration of organic solvents with 7-dehydrocholesterol or 25-hydroxy-7-dehydrocholesterol or OH protected forms thereof
CN115746075A (en) * 2022-10-14 2023-03-07 浙江新和成股份有限公司 Method for recovering and purifying 7-dehydrocholesterol in high-impurity-content photochemical reaction liquid in vitamin D3 production process

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102702295A (en) * 2012-05-24 2012-10-03 河南利伟生物药业股份有限公司 Preparation method of 7-dehydrocholesterol

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102702295A (en) * 2012-05-24 2012-10-03 河南利伟生物药业股份有限公司 Preparation method of 7-dehydrocholesterol

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
韦昌金等: "《维生素D-3合成新工艺的初步设想》", 《化工进展》, vol. 22, no. 10, 31 December 2003 (2003-12-31), pages 1098 - 1101 *
黄时海等: "《虾Y-器官7、8-脱氢酶转化胆固醇为7-脱氢胆固醇研究》", 《安徽农业科学》, vol. 39, no. 25, 31 December 2011 (2011-12-31), pages 15397 - 15399 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020104353A1 (en) * 2018-11-19 2020-05-28 Dsm Ip Assets B.V. 7-dehydrocholesterol-hemimethanolate
CN113015739A (en) * 2018-11-19 2021-06-22 帝斯曼知识产权资产管理有限公司 7-dehydrocholesterol-hemimethanolic compounds
CN115397832A (en) * 2020-04-23 2022-11-25 帝斯曼知识产权资产管理有限公司 Nanofiltration of organic solvents with 7-dehydrocholesterol or 25-hydroxy-7-dehydrocholesterol or OH protected forms thereof
CN112979738A (en) * 2021-03-02 2021-06-18 浙江新和成股份有限公司 Crystallization purification method of 7-dehydrocholesterol and application thereof in VD3 production
CN112979738B (en) * 2021-03-02 2022-04-05 浙江新和成股份有限公司 Crystallization purification method of 7-dehydrocholesterol and application thereof in VD3 production
CN115746075A (en) * 2022-10-14 2023-03-07 浙江新和成股份有限公司 Method for recovering and purifying 7-dehydrocholesterol in high-impurity-content photochemical reaction liquid in vitamin D3 production process

Also Published As

Publication number Publication date
CN104017042B (en) 2016-01-06

Similar Documents

Publication Publication Date Title
CN104017042B (en) A kind of separation purification method of 7-DHC
CN104356016B (en) A method of with recycling preparation 3- isobutylglutaric acid monoamides
CN109180749B (en) Method for preparing high-purity N-acetylneuraminic acid hydrate by using supersaturation crystallization method
CN110790805A (en) Method for extracting chenodeoxycholic acid from pig bile paste
CN102320953B (en) Method for preparing natural alpha-linolenic acid from crude oil of idesia polycarpa var.vestita diels
CN109776646B (en) Method for preparing high-purity cholesterol by continuous countercurrent micro-channel extraction
CN103420881A (en) Novel method for preparing medicinal despun hydroxyl methionine calcium
CN103319486B (en) Synthesize 4H imidazos [1,5 a] [1,4] Benzodiazepine, the particularly method of midazolam
CN110724081A (en) Efficient production process of vitamin D2
CN103896956B (en) A kind of method extracting sesamin from sesame seed coat
CN107488101A (en) The preparation method of n-octacosanol
CN103864614B (en) The method of separation and purification DHA-EE from the DHA grease of fermentable
CN115960156A (en) Method for extracting ergosterol by using yeast
US20110201054A1 (en) Process for improved recovery of fermentation products from intracellular and extracellular presence
CN106892791A (en) Extract method and the medicine containing squalene of plant source spiny dogfish ene compositions and its preparation method and application
CN113354526B (en) Alkali purification method of coenzyme Q10
CN107382697A (en) A kind of method that efficient separating prepares the naphthoic acid of (S) tetrahydrochysene 1
CN106890200A (en) Extract method and the medicine containing squalene of plant source spiny dogfish ene compositions and its preparation method and application
CN102875635A (en) Method for comprehensively extracting protodioscin and dioscin from dioscorea nipponica
CN107011403B (en) A kind of preparation method for improving cholesterol purity
CN106890199A (en) Extract method and the medicine containing squalene of plant source spiny dogfish ene compositions and its preparation method and application
CN101289410A (en) Method for preparing D-phenylalanine
CN110437248B (en) Production method of milbemycins capable of shortening production cycle
CN100509756C (en) Method of extracting and splitting phenylalanine by D-dialkyl tartrate
CN109879925A (en) A kind of preparation method of phytosterin ester

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 454850 Henan city of Jiaozuo province Wenxian County industrial agglomeration Zone Xinyuan Road

Applicant after: Henan Liwei Biological Pharmaceutical Co.,Ltd.

Address before: The southern section of Henan City Road 450000 tube since the city of Zhengzhou Province

Applicant before: Henan Liwei Biological Pharmaceutical Co.,Ltd.

COR Change of bibliographic data
C14 Grant of patent or utility model
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A Method for Separation and Purification of 7-Dehydrocholesterol

Effective date of registration: 20221109

Granted publication date: 20160106

Pledgee: Wenxian Rural Credit Cooperative Association Renmin Road Credit Cooperative

Pledgor: Henan Liwei Biological Pharmaceutical Co.,Ltd.

Registration number: Y2022980021218